According to the statistical results of the above baseline tables, the UGT1A1*6 mutation is related to hyperbilirubinemia, the amount of CPT-11 dose reduction and whether dose reduction of CPT-11 took place, the degree of vomiting, the severity of diarrhea and neutropenia. The gene discussed is UGT1A1; the disease is neutropenia.